论文部分内容阅读
解决厂商冲突有这样一个过程:从短期激励变成中长期激励,由简单的交易服务变成综合的服务,包括文化、人力资源、组织、流程对接和规范对接上的服务,逐步实现“厂商价值一体化”。这是保证医药行业从理念、策略、操作层面上解决厂商冲突的关键。看行业风云变幻,成就多少英雄。作为一种新营利模式的首推者——国内品牌药经营先锋康恩贝集团能否成就中国本土“沃尔玛”梦想,我们拭目以待。
To solve the conflict between manufacturers, there is such a process: from short-term incentives to mid- and long-term incentives, from simple transaction services into comprehensive services, including cultural, human resources, organizational, process docking and standard docking services, and gradually realize the “manufacturer value Integration. ” This is to ensure that the pharmaceutical industry from the concept, strategy, operational level, the key to resolve conflicts manufacturers. Look at the changing industry, how many achievements in the hero. As a new profit-making model of the pioneer - the domestic brand drug business pioneer Conba Group can achieve China’s domestic “Wal-Mart” dream, we’ll see.